New insights into KATP channel gene mutations and neonatal diabetes mellitus (original) (raw)

• Rorsman, P. & Ashcroft, F. M. Pancreatic β-cell electrical activity and insulin secretion: of mice and men. Physiol. Rev. 98, 117–214 (2018).
  Article CAS PubMed Google Scholar
• Flanagan, S. E. et al. Update of variants identified in the pancreatic β-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes. Hum. Mutat. https://doi.org/10.1002/humu.23995 (2020).
• Martin, G. M. et al. Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating. Elife 6, e24149 (2017).
  Article PubMed PubMed Central Google Scholar
• Martin, G. M., Kandasamy, B., DiMaio, F., Yoshioka, C. & Shyng, S.-L. Anti-diabetic drug binding site in a mammalian KATP channel revealed by cryo-EM. Elife 6, e31054 (2017).
  Article PubMed PubMed Central Google Scholar
• Li, N. et al. Structure of a pancreatic ATP-sensitive potassium channel. Cell 168, 101–110.e10 (2017).
  Article CAS PubMed Google Scholar
• Lee, K. P. K., Chen, J. & MacKinnon, R. Molecular structure of human KATP in complex with ATP and ADP. Elife 6, e32481 (2017).
  Article PubMed PubMed Central Google Scholar
• Wu, J.-X. et al. Ligand binding and conformational changes of SUR1 subunit in pancreatic ATP-sensitive potassium channels. Protein Cell 9, 553–567 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, D., Wang, M., Wu, J.-X., Kang, Y. & Chen, L. The structural basis for the binding of repaglinide to the pancreatic KATP channel. Cell Rep. 27, 1848–1857.e4 (2019).
  Article CAS PubMed Google Scholar
• Martin, G. M. et al. Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM. Elife 8, e46417 (2019).
  Article PubMed PubMed Central Google Scholar
• Puljung, M. C. Cryo-electron microscopy structures and progress toward a dynamic understanding of KATP channels. J. Gen. Physiol. 150, 653–659 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Cook, D. L. & Hales, N. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature 311, 271–273 (1984).
  Article CAS PubMed Google Scholar
• Shyng, S. L. & Nichols, C. G. Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282, 1138–1141 (1998).
  Article CAS PubMed Google Scholar
• Aguilar-Bryan, L. et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268, 423–426 (1995).
  Article CAS PubMed Google Scholar
• Nichols, C. G. et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272, 1785–1787 (1996).
  Article CAS PubMed Google Scholar
• Mikhailov, M. V. et al. 3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1. EMBO J. 24, 4166–4175 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Tucker, S. J., Gribble, F. M., Zhao, C., Trapp, S. & Ashcroft, F. M. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 387, 179–183 (1997).
  Article CAS PubMed Google Scholar
• Hattersley, A. T. & Ashcroft, F. M. Activating mutations in Kir6.2 and neonatal diabetes mellitus: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54, 2503–2513 (2005).
  Article CAS PubMed Google Scholar
• Ashcroft, F. M. ATP-sensitive K+ channels and disease: from molecule to malady. Am. J. Physiol. Metab. 293, E880–E889 (2007).
  CAS Google Scholar
• Stanley, C. A. Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders. J. Clin. Endocrinol. Metab. 101, 815–826 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Kakei, M., Noma, A. & Shibasaki, T. Properties of adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J. Physiol. 363, 441–462 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Ashcroft, F. M. Adenosine 5’-triphosphate-sensitive potassium channels. Annu. Rev. Neurosci. 11, 97–118 (1988).
  Article CAS PubMed Google Scholar
• Dabrowski, M., Tarasov, A. & Ashcroft, F. M. Mapping the architecture of the ATP-binding site of the KATP channel subunit Kir6.2. J. Physiol. 557, 347–354 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Pratt, E. B., Zhou, Q., Gay, J. W. & Shyng, S.-L. Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels. J. Gen. Physiol. 140, 175–187 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Masia, R. et al. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes mellitus. Diabetes 56, 328–336 (2007).
  Article CAS PubMed Google Scholar
• Shimomura, K. et al. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes mellitus produce different functional effects. Diabetes 55, 1705–1712 (2006).
  Article CAS PubMed Google Scholar
• Männikkö, R. et al. Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes mellitus and neurological symptoms. Hum. Mol. Genet. 19, 963–972 (2010).
  Article PubMed CAS Google Scholar
• Proks, P. et al. Molecular basis of Kir6.2 mutations associated with neonatal diabetes mellitus or neonatal diabetes mellitus plus neurological features. Proc. Natl Acad. Sci. USA 101, 17539–17544 (2004).
  Article CAS PubMed Google Scholar
• Shimomura, K. et al. Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes mellitus and hyperinsulinism. EMBO Mol. Med. 1, 166–177 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tarasov, A. I. et al. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes mellitus. Diabetes Obes. Metab. 9, 46–55 (2007).
  Article CAS PubMed Google Scholar
• Girard, C. A. J. et al. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes mellitus. Pflugers Arch. 453, 323–332 (2006).
  Article CAS PubMed Google Scholar
• Enkvetchakul, D., Loussouran, G., Makhina, E., Shyng, S. L. & Nicjols, C. G. The kinetic and physical basis of KATP channel gating: toward a unified molecular understanding. Biophys. J. 78, 2334–2348 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuo, M., Kioka, N., Amachi, T. & Ueda, K. ATP binding properties of the nucleotide-binding folds of SUR1. J. Biol. Chem. 274, 37479–37482 (1999).
  Article CAS PubMed Google Scholar
• Zingman, L. V. et al. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K-conductance. Neuron 31, 233–245 (2001).
  Article CAS PubMed Google Scholar
• Puljung, M., Vedovato, N., Usher, S. & Ashcroft, F. Activation mechanism of ATP-sensitive K+ channels explored with real-time nucleotide binding. Elife 8, e41103 (2019).
  Article PubMed PubMed Central Google Scholar
• Babenko, A. P. et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N. Engl. J. Med. 355, 456–466 (2006).
  Article CAS PubMed Google Scholar
• de Wet, H. et al. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes mellitus. EMBO Rep. 9, 648–654 (2008).
  Article PubMed CAS PubMed Central Google Scholar
• Proks, P., Shimomura, K., Craig, T. J., Girard, C. A. J. & Ashcroft, F. M. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Hum. Mol. Genet. 16, 2011–2019 (2007).
  Article CAS PubMed Google Scholar
• de Wet, H. et al. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes mellitus. Proc. Natl Acad. Sci. USA 104, 18988–18992 (2007).
  Article PubMed Google Scholar
• Männikkö, R. et al. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes mellitus. Diabetes 60, 1813–1822 (2011).
  Article PubMed CAS PubMed Central Google Scholar
• Zhou, Q. et al. Neonatal diabetes mellitus caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels. J. Clin. Endocrinol. Metab. 95, E473–E478 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Koster, J. C., Kurata, H. T., Enkvetchakul, D. & Nichols, C. G. DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP Channel. Biophys. J. 95, 4689–4697 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Flanagan, S. E., Edghill, E. L., Gloyn, A. L., Ellard, S. & Hattersley, A. T. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49, 1190–1197 (2006).
  Article CAS PubMed Google Scholar
• Flanagan, S. E. et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes mellitus and permanent diabetes in childhood or adulthood. Diabetes 56, 1930–1937 (2007).
  Article CAS PubMed Google Scholar
• Russo, L. et al. Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia 54, 1693–1701 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Iafusco, D. et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol. 49, 405–408 (2012).
  Article CAS PubMed Google Scholar
• Grulich-Henn, J. et al. Entities and frequency of neonatal diabetes mellitus: data from the diabetes documentation and quality management system (DPV). Diabet. Med. 27, 709–712 (2010).
  Article CAS PubMed Google Scholar
• Wiedemann, B. et al. Incidence of neonatal diabetes mellitus in Austria-calculation based on the Austrian diabetes register. Pediatr. Diabetes 11, 18–23 (2010).
  Article PubMed Google Scholar
• Habeb, A. M. et al. Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr. Diabetes 13, 499–505 (2012).
  Article CAS PubMed Google Scholar
• Gloyn, A. L. et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes mellitus. N. Engl. J. Med. 350, 1838–1849 (2004).
  Article CAS PubMed Google Scholar
• Gloyn, A. L. et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum. Mol. Genet. 14, 925–934 (2005).
  Article CAS PubMed Google Scholar
• Tarasov, A. I. et al. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults. Diabetes 57, 1595–1604 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• De Franco, E. et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes mellitus: an international cohort study. Lancet 386, 957–963 (2015).
  Article PubMed PubMed Central Google Scholar
• Karschin, C., Ecke, C., Ashcroft, F. M. & Karschin, A. Overlapping distribution of the KATP channel-forming Kir6.2 subunit and the sulphonylurea receptor SUR1 in rodent brain. FEBS Lett. 401, 59–64 (1997).
  Article CAS PubMed Google Scholar
• Clark, R. et al. Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes mellitus is neuronal in origin. Science 329, 458–461 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Vedovato, N. et al. Neonatal diabetes mellitus caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk. Diabetologia 59, 1430–1436 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Tarasov, A. I. et al. A Kir6.2 mutation causing neonatal diabetes mellitus impairs electrical activity and insulin secretion from INS-1 β-cells. Diabetes 55, 3075–3082 (2006).
  Article CAS PubMed Google Scholar
• Gloyn, A. L. et al. Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568–572 (2003).
  Article CAS PubMed Google Scholar
• Villareal, D. T. et al. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes 58, 1869–1878 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hamming, K. S. C. et al. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11; E23K and ABCC8; S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K+ channel. Diabetes 58, 2419–2424 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ashfield, R., Gribble, F. M., Ashcroft, S. J. & Ashcroft, F. M. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48, 1341–1347 (1999).
  Article CAS PubMed Google Scholar
• Dabrowski, M., Wahl, P., Holmes, W. E. & Ashcroft, F. M. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels. Diabetologia 44, 747–756 (2001).
  Article CAS PubMed Google Scholar
• Gribble, F. M., Tucker, S. J. & Ashcroft, F. M. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J. Physiol. 504, 35–45 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Proks, P., de Wet, H. & Ashcroft, F. M. Molecular mechanism of sulphonylurea block of KATP channels carrying mutations that impair ATP inhibition and cause neonatal diabetes mellitus. Diabetes 62, 3909–3919 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gloyn, A. L. et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes mellitus syndrome and other neurological features. Eur. J. Hum. Genet. 14, 824–830 (2006).
  Article CAS PubMed Google Scholar
• Trapp, S., Proks, P., Tucker, S. J. & Ashcroft, F. M. Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J. Gen. Physiol. 112, 333–349 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Proks, P. et al. A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep. 6, 470–475 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gillis, K. D. et al. Effects of sulfonamides on a metabolite-regulated ATP-sensitive K+ channel in rat pancreatic B-cells. Am. J. Physiol. 257, C1119–C1127 (1989).
  Article CAS PubMed Google Scholar
• Koster, J. C., Remedi, M. S., Dao, C. & Nichols, C. G. ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes mellitus: implications for pharmacogenomic therapy. Diabetes 54, 2645–2654 (2005).
  Article CAS PubMed Google Scholar
• Pearson, E. R. et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N. Engl. J. Med. 355, 467–477 (2006).
  Article CAS PubMed Google Scholar
• Zung, A., Glaser, B., Nimri, R. & Zadik, Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J. Clin. Endocrinol. Metab. 89, 5504–5507 (2004).
  Article CAS PubMed Google Scholar
• Bowman, P. et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes mellitus due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 6, 637–646 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Shigeto, M. et al. GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation. J. Clin. Invest. 125, 4714–4728 (2015).
  Article PubMed PubMed Central Google Scholar
• Kato, M., Ma, H. T. & Tatemoto, K. GLP-1 depolarizes the rat pancreatic beta cell in a Na+-dependent manner. Regul. Pept. 62, 23–27 (1996).
  Article CAS PubMed Google Scholar
• Gromada, J. et al. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47, 57–65 (1998).
  Article CAS PubMed Google Scholar
• Gromada, J., Ding, W. G., Barg, S., Renstrom, E. & Rorsman, P. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors. Pflugers Arch. 434, 515–524 (1997).
  Article CAS PubMed Google Scholar
• Babiker, T. et al. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes mellitus is determined by the mutation and duration of diabetes. Diabetologia 59, 1162–1166 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Haythorne, E. et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Nat. Commun. 10, 2474 (2019).
  Article PubMed PubMed Central Google Scholar
• Brereton, M. F. et al. Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells. Nat. Commun. 7, 13496 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Remedi, M. S. et al. Secondary consequences of β cell inexcitability: identification and prevention in a murine model of KATP-induced neonatal diabetes mellitus. Cell Metab. 9, 140–151 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Marshall, B. A. et al. Remission of severe neonatal diabetes mellitus with very early sulfonylurea treatment. Diabetes Care 38, e38–e39 (2015).
  Article PubMed PubMed Central Google Scholar
• Misra, S. et al. Permanent neonatal diabetes mellitus: combining sulfonylureas with insulin may be an effective treatment. Diabet. Med. 35, 1291–1296 (2018).
  Article Google Scholar
• Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R. & Turner, R. C. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet. Med. 15, 297–303 (1998).
  Article CAS PubMed Google Scholar
• Beltrand, J. et al. Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes mellitus owing to potassium channel mutations. Diabetes Care 38, 2033–2041 (2015).
  Article CAS PubMed Google Scholar
• Busiah, K. et al. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study. Lancet Diabetes Endocrinol. 1, 199–207 (2013).
  Article CAS PubMed Google Scholar
• Lahmann, C., Kramer, H. B. & Ashcroft, F. M. Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS One 10, e0134476 (2015).
  Article PubMed CAS PubMed Central Google Scholar
• Fendler, W. et al. Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion. Diabetes Care 36, 2311–2316 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Myngheer, N. et al. Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11 related neonatal diabetes mellitus. Diabetes Care 37, 3333–3335 (2014).
  Article PubMed PubMed Central Google Scholar
• De Franco, E. et al. Analysis of cell-free fetal DNA for non-invasive prenatal diagnosis in a family with neonatal diabetes mellitus. Diabet. Med. 34, 582–585 (2017).
  Article PubMed CAS Google Scholar
• Alkorta-Aranburu, G. et al. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol. Genet. Metab. 113, 315–320 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, L. et al. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. Diabetologia 56, 2609–2618 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Craig, T. J. et al. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes mellitus reveals a site of interaction between Kir6.2 and SUR1. J. Clin. Endocrinol. Metab. 94, 2551–2557 (2009).
  Article CAS PubMed Google Scholar
• Proks, P., Girard, C., Baevre, H., Njølstad, P. R. & Ashcroft, F. M. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes mellitus, and response to sulfonylurea therapy. Diabetes 55, 1731–1737 (2006).
  Article CAS PubMed Google Scholar
• Vaxillaire, M. et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes mellitus in a large cohort of French patients. Diabetes 53, 2719–2722 (2004).
  Article CAS PubMed Google Scholar
• Zhang, M. et al. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds. J. Pediatr. Endocrinol. Metab. 28, 877–884 (2015).
  CAS PubMed Google Scholar
• Yorifuji, T. et al. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes mellitus, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90, 3174–3178 (2005).
  Article CAS PubMed Google Scholar
• Hashimoto, Y. et al. Molecular and clinical features of KATP-channel neonatal diabetes mellitus in Japan. Pediatr. Diabetes 18, 532–539 (2017).
  Article CAS PubMed Google Scholar
• Mlynarski, W. et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat. Clin. Pract. Neurol. 3, 640 (2007).
  Article CAS PubMed Google Scholar
• Klupa, T. et al. Efficacy and safety of sulfonylurea use in permanent neonatal diabetes mellitus due to KCNJ11 gene mutations: 34-month median follow-up. Diabetes Technol. Ther. 12, 387–391 (2010).
  Article CAS PubMed Google Scholar
• Bennett, J. T. et al. Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism. Mol. Genet. Metab. 114, 451–458 (2015).
  Article CAS PubMed Google Scholar
• Suzuki, S. et al. Molecular basis of neonatal diabetes mellitus in Japanese patients. J. Clin. Endocrinol. Metab. 92, 3979–3985 (2007).
  Article CAS PubMed Google Scholar
• Fraser, C. S. et al. Amino acid properties may be useful in predicting clinical outcome in patients with Kir6.2 neonatal diabetes mellitus. Eur. J. Endocrinol. 167, 417–421 (2012).
  Article CAS PubMed Google Scholar
• Massa, O. et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes mellitus. Hum. Mutat. 25, 22–27 (2004).
  Article CAS Google Scholar
• Tammaro, P., Proks, P. & Ashcroft, F. M. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes mellitus on cloned cardiac KATP channels. J. Physiol. 571, 3–14 (2006).
  Article CAS PubMed Google Scholar
• Huopio, H. et al. Clinical, genetic, and biochemical characteristics of early-onset diabetes in the Finnish population. J. Clin. Endocrinol. Metab. 101, 3018–3026 (2016).
  Article CAS PubMed Google Scholar
• Koster, J. C. et al. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes mellitus and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J. Clin. Endocrinol. Metab. 93, 1054–1061 (2008).
  Article CAS PubMed Google Scholar
• Khadilkar, V. V. et al. KCNJ11 activating mutation in an Indian family with remitting and relapsing diabetes. Indian J. Pediatr. 77, 551–554 (2010).
  Article CAS PubMed Google Scholar
• Sachie, I. et al. DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas. J. Pediatric Endocrinol. Metab. 26, 143 (2013).
  Google Scholar
• Männikkö, R. et al. A conserved tryptophan at the membrane-water interface acts as a gatekeeper for Kir6.2/SUR1 channels and causes neonatal diabetes mellitus when mutated. J. Physiol. 589, 3071–3083 (2011).
  Article PubMed CAS PubMed Central Google Scholar
• O’Connell, S. M. et al. The value of in vitro studies in a case of neonatal diabetes mellitus with a novel Kir6.2-W68G mutation. Clin. Case Rep. 3, 884–887 (2015).
  Article PubMed PubMed Central Google Scholar
• Tammaro, P. et al. A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes mellitus without the expected neurological complications. Diabetologia 51, 802–810 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, W.-L. et al. A novel mutation of KCNJ11 gene in a patient with permanent neonatal diabetes mellitus. Diabetes Res. Clin. Pract. 104, e29–e32 (2014).
  Article CAS PubMed Google Scholar
• Shimomura, K. et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology 69, 1342–1349 (2007).
  Article CAS PubMed Google Scholar
• Shimomura, K. et al. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue. Diabet. Med. 27, 225–229 (2010).
  Article CAS PubMed Google Scholar
• Ahn, S. Y., Kim, G.-H. & Yoo, H.-W. Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation. Korean J. Pediatr. 58, 309–312 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, Y.-W. et al. Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between KATP gain of channel activity and loss of channel expression. PLoS One 8, e63758 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Battaglia, D. et al. Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation. Pediatr. Diabetes 13, 656–660 (2012).
  Article PubMed PubMed Central Google Scholar
• D’Amato, E. et al. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation. Diabet. Med. 25, 651–656 (2008).
  Article PubMed CAS Google Scholar
• Bonnefond, A. et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care 37, 460–467 (2014).
  Article CAS PubMed Google Scholar
• Joshi, R. & Phatarpekar, A. Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene. World J. Pediatr. 7, 371–372 (2011).
  Article CAS PubMed Google Scholar
• Jesic, M. M., Jesic, M. D., Maglajlic, S., Sajic, S. & Necic, S. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation. Diabetes Res. Clin. Pract. 91, e1–e3 (2011).
  Article CAS PubMed Google Scholar
• Gole, E., Oikonomou, S., Ellard, S., De Franco, E. & Karavanaki, K. A novel KCNJ11 mutation associated with transient neonatal diabetes mellitus. J. Clin. Res. Pediatr. Endocrinol. 10, 175–178 (2018).
  Article PubMed PubMed Central Google Scholar
• Jahnavi, S. et al. Clinical and molecular characterization of neonatal diabetes mellitus and monogenic syndromic diabetes in Asian Indian children. Clin. Genet. 83, 439–445 (2013).
  Article CAS PubMed Google Scholar
• Siklar, Z. et al. Transient neonatal diabetes mellitus with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant. J. Pediatr. Endocrinol. Metab. 24, 1077–1080 (2011).
  PubMed Google Scholar
• Tammaro, P., Girard, C., Molnes, J., Njølstad, P. R. & Ashcroft, F. M. Kir6.2 mutations causing neonatal diabetes mellitus provide new insights into Kir6.2-SUR1 interactions. EMBO J. 24, 2318–2330 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sagen, J. V. et al. Permanent neonatal diabetes mellitus due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53, 2713–2718 (2004).
  Article CAS PubMed Google Scholar
• Philla, K. Q., Bauer, A. J., Vogt, K. S. & Greeley, S. A. W. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes mellitus owing to a KCNJ11 F333L mutation. Diabetes Care 36, e201 (2013).
  Article PubMed PubMed Central Google Scholar
• Sang, Y., Yang, W., Yan, J. & Wu, Y. KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age. J. Pediatr. Endocrinol. Metab. 27, 519–523 (2014).
  Article CAS PubMed Google Scholar
• Lin, Y.-W. et al. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic KATP channels cause neonatal diabetes mellitus by perturbing the coupling between Kir6.2 and SUR1 subunits. Channels 6, 133–138 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ellard, S. et al. Permanent neonatal diabetes mellitus caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am. J. Hum. Genet. 81, 375–382 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Rafiq, M. et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31, 204–209 (2008).
  Article CAS PubMed Google Scholar
• Zwaveling-Soonawala, N. et al. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes mellitus (DEND) syndrome and a novel ABCC8 gene mutation. Diabetologia 54, 469–471 (2011).
  Article CAS PubMed Google Scholar
• Globa, E. et al. Neonatal diabetes mellitus in Ukraine: incidence, genetics, clinical phenotype and treatment. J. Pediatr. Endocrinol. Metab. 28, 1279–1286 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Shield, J. P. H. et al. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes mellitus and hemihypertrophy. Diabetes 57, 255–258 (2008).
  Article CAS PubMed Google Scholar
• Gonsorcikova, L. et al. Familial mild hyperglycemia associated with a novel ABCC8-V84I mutation within three generations. Pediatr. Diabetes 12, 266–269 (2011).
  Article PubMed Google Scholar
• Busiah, K., Verkarre, V., Cave, H., Scharfmann, R. & Polak, M. Human pancreas endocrine cell populations and activating ABCC8 mutations. Horm. Res. Paediatr. 82, 59–64 (2014).
  Article CAS PubMed Google Scholar
• Bowman, P. et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 55, 123–127 (2012).
  Article CAS PubMed Google Scholar
• Patch, A. M., Flanagan, S. E., Boustred, C., Hattersley, A. T. & Ellard, S. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes mellitus, permanent neonatal diabetes mellitus or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes. Metab. 9, 28–39 (2007).
  Article CAS PubMed Google Scholar
• Vaxillaire, M. et al. New ABCC8 mutations in relapsing neonatal diabetes mellitus and clinical features. Diabetes 56, 1737–1741 (2007).
  Article CAS PubMed Google Scholar
• Cao, B. et al. Genetic analysis and follow-up of 25 neonatal diabetes mellitus patients in China. J. Diabetes Res. 2016, 6314368 (2016).
  Article PubMed CAS Google Scholar
• Balamurugan, K. et al. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children. Pediatr. Diabetes 20, 397–407 (2019).
  Article CAS PubMed Google Scholar
• Babenko, A. P. & Vaxillaire, M. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8). FEBS Lett. 585, 3555–3559 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fanciullo, L. et al. Sulfonylurea-responsive neonatal diabetes mellitus diagnosed through molecular genetics in two children and in one adult after a long period of insulin treatment. Acta Biomed. 83, 56–61 (2012).
  PubMed Google Scholar
• Masia, R. et al. A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM). Diabetes 56, 1357–1362 (2007).
  Article CAS PubMed Google Scholar
• Takagi, M. et al. A case of transient neonatal diabetes mellitus due to a novel mutation in ABCC8. Clin. Pediatr. Endocrinol. 25, 139–141 (2016).
  Article PubMed PubMed Central Google Scholar
• Dalvi, N. N. H. et al. Genetically confirmed neonatal diabetes mellitus: a single centre experience. Indian J. Pediatr. 84, 86–88 (2017).
  Article PubMed Google Scholar
• Li, X. et al. Early transition from insulin to sulfonylureas in neonatal diabetes mellitus and follow-up: experience from China. Pediatr. Diabetes 19, 251–258 (2018).
  Article CAS PubMed Google Scholar
• Anik, A. et al. A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis. J. Pediatr. Endocrinol. Metab. 27, 533–537 (2014).
  CAS PubMed Google Scholar
• Demirbilek, H. et al. Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes mellitus from the south-eastern region of Turkey: predominance of non-KATP channel mutations. Eur. J. Endocrinol. 172, 697–705 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Katanic, D. et al. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes mellitus caused by the novel ABCC8 gene mutation and three years follow-up. Diabetes Res. Clin. Pract. 129, 59–61 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, R. et al. A case of a Japanese patient with neonatal diabetes mellitus caused by a novel mutation in the ABCC8 gene and successfully controlled with oral glibenclamide. Clin. Pediatr. Endocrinol. 24, 191–193 (2015).
  Article PubMed PubMed Central Google Scholar
• Shima, K. R. et al. Heterogeneous nature of diabetes in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene. Endocr. J. 65, 1055–1059 (2018).
  Article CAS PubMed Google Scholar
• Flanagan, S. E. et al. An ABCC8 nonsense mutation causing neonatal diabetes mellitus through altered transcript expression. J. Clin. Res. Pediatr. Endocrinol. 9, 260–264 (2017).
  Article PubMed PubMed Central Google Scholar
• Rubio-Cabezas, O., Flanagan, S. E., Damhuis, A., Hattersley, A. T. & Ellard, S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr. Diabetes 13, 322–325 (2012).
  Article CAS PubMed Google Scholar
• Klee, P. et al. A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation. Diabetes Metab. 38, 179–182 (2012).
  Article CAS PubMed Google Scholar
• Chen, H., Chen, R., Yuan, X., Yang, X. & Chen, S. ABCC8 gene analysis, treatment and follow-up of an infant with neonatal diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 34, 571–575 (2017).
  PubMed Google Scholar
• Mak, C. M. et al. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation. Diagn. Mol. Pathol. 21, 56–59 (2012).
  Article CAS PubMed Google Scholar
• Cattoni, A., Jackson, C., Bain, M., Houghton, J. & Wei, C. Phenotypic variability in two siblings with monogenic diabetes due to the same ABCC8 gene mutation. Pediatr. Diabetes 20, 482–485 (2019).
  Article CAS PubMed Google Scholar
• Thakkar, A. N., Muranjan, M. N., Karande, S. & Shah, N. S. Neonatal diabetes mellitus due to a novel ABCC8 gene mutation mimicking an organic acidemia. Indian J. Pediatr. 81, 702–704 (2014).
  Article PubMed Google Scholar
• Poovazhagi, V. & Thangavelu, S. Relapsing transient neonatal diabetes mellitus due to ABCC8 mutation. J. Mol. Genet. Med. 8, 136 (2014).
  Google Scholar
• Babenko, A. P. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling. J. Biol. Chem. 283, 8778–8782 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Christesen, H. B. T., Sjöblad, S., Brusgaard, K., Papadopoulou, D. & Brock Jacobsen, B. Permanent neonatal diabetes mellitus in a child with an ABCC8 gene mutation. European Society of Paediatrics (ESPE)/LWPES 7th joint meeting paediatric endocrinology, Lyon 22/9 2005. Horm. Res. 64 (Suppl. 1), 135 (2005).
  Google Scholar
• Vasanwala, R. F., Lim, S. H., Ellard, S. & Yap, F. Neonatal diabetes mellitus in a Singapore Children’s Hospital: molecular diagnoses of four cases. Ann. Acad. Med. Singap. 43, 314–319 (2014).
  PubMed Google Scholar
• Takagi, T. et al. Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus. J. Diabetes Investig. 4, 269–273 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ganesh, R., Suresh, N., Vasanthi, T. & Ravikumar, K. G. Neonatal diabetes mellitus: a case series. Indian Pediatr. 54, 33–36 (2017).
  Article PubMed Google Scholar
• Ovsyannikova, A. K. et al. ABCC8-related maturity-onset diabetes of the young (MODY12): clinical features and treatment perspective. Diabetes Ther. 7, 591–600 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Taberner, P. et al. Clinical and genetic features of Argentinian children with diabetes-onset before 12 months of age: successful transfer from insulin to oral sulfonylurea. Diabetes Res. Clin. Pract. 117, 104–110 (2016).
  Article CAS PubMed Google Scholar
• Helleskov, A. et al. Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism: a multinational cohort study. Front. Endocrinol. 8, 156 (2017).
  Article Google Scholar
• Yan, F.-F. et al. Congenital hyperinsulinism–associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels. Diabetes 56, 2339–2348 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, Y.-W., MacMullen, C., Ganguly, A., Stanley, C. A. & Shyng, S.-L. A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels. J. Biol. Chem. 281, 3006–3012 (2006).
  Article CAS PubMed Google Scholar
• Stansfeld, P. J., Hopkinson, R., Ashcroft, F. M. & Sansom, M. S. P. PIP2-binding site in Kir channels: definition by multiscale biomolecular simulations. Biochemistry 48, 10926–10933 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Haider, S., Tarasov, A. I., Craig, T. J., Sansom, M. S. P. & Ashcroft, F. M. Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis. EMBO J. 26, 3749–3759 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Shyng, S. L., Cukras, C. A., Harwood, J. & Nichols, C. G. Structural determinants of PIP2 regulation of inward rectifier KATP channels. J. Gen. Physiol. 116, 599–608 (2000).
  Article CAS PubMed PubMed Central Google Scholar